Brpf1 Activators
Brpf1 Activators are a diverse set of chemical compounds that indirectly promote the functional activity of Brpf1 by manipulating the chromatin environment and the competitive landscape of histone acetyltransferases. Trichostatin A, SAHA, MGCD0103, and Scriptaid are all histone deacetylase inhibitors that contribute to a more relaxed chromatin structure, thus facilitating Brpf1's access to histone substrates and enhancing its histone acetyltransferase functionality. This relaxed chromatin state is crucial for Brpf1 to modify histones effectively, promoting gene expression patterns that are conducive to its activation. Similarly, the selective p300/CBP inhibitors C646, Garcinol, and I-CBP112 restrict the acetylation activity of these competitive histone acetyltransferases, permitting Brpf1 to utilize acetyl-CoA substrates with greater efficiency and specificity.
These inhibitors ensure thatBrpf1 Activators comprise a spectrum of chemical entities that indirectly potentiate the functional activity of Brpf1 by modulating chromatin dynamics and histone acetylation competition. Inhibitors of histone deacetylase such as Trichostatin A, SAHA (Vorinostat), MGCD0103, and Scriptaid diminish deacetylation, favoring a more open chromatin conformation that allows better access for Brpf1 to its histone targets, thereby facilitating its intrinsic histone acetyltransferase (HAT) activity. This open state of chromatin is essential for Brpf1 to effectively acetylate histones, which in turn can influence gene expression patterns that are essential for its activation. Furthermore, by curtailing the acetyltransferase actions of p300/CBP through the use of C646, Garcinol, and I-CBP112, these inhibitors directly ensure that Brpf1 encounters less competition for acetyl-CoA substrates, thereby indirectly increasing Brpf1's ability to acetylate histones more efficiently, enhancing its role in gene regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Anacardic Acid is a histone acetyltransferase inhibitor that can lead to enhanced Brpf1 activity by reducing competition, enabling Brpf1 to acetylate histones more efficiently and influence gene expression relevant to its functional activation. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 is a selective p300/CBP histone acetyltransferase inhibitor that indirectly enhances Brpf1 activity by reducing competition for acetyl-CoA substrates, thus allowing Brpf1 to modify histones more effectively. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is known to inhibit histone acetyltransferase enzymes, thereby potentially enhancing Brpf1 activity by diminishing competitive acetylation reactions, which could lead to increased Brpf1-mediated acetylation of histone targets. | ||||||
Garcinol | 78824-30-3 | sc-200891 sc-200891A | 10 mg 50 mg | $124.00 $502.00 | 13 | |
Garcinol is an inhibitor of p300/CBP histone acetyltransferases, which may enhance Brpf1 activity by decreasing competitive acetylation and allowing Brpf1 to acetylate histone targets more efficiently. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA is a histone deacetylase inhibitor that can indirectly enhance Brpf1 activity by promoting an open chromatin configuration, facilitating the binding and function of Brpf1 in acetylating histones. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
MGCD0103, a histone deacetylase inhibitor, could increase Brpf1 activity by allowing a more accessible chromatin environment for Brpf1 to exert its histone acetyltransferase activity, as it preferentially affects gene expression. | ||||||
Scriptaid | 287383-59-9 | sc-202807 sc-202807A | 1 mg 5 mg | $64.00 $183.00 | 11 | |
Scriptaid is a histone deacetylase inhibitor, which may enhance Brpf1 activity by promoting chromatin relaxation and enabling Brpf1 to more effectively acetylate histones, thereby influencing gene expression. | ||||||
I-CBP112 | 1640282-31-0 | sc-507494 | 25 mg | $400.00 | ||
I-CBP112 is a selective CBP/p300 inhibitor that can enhance Brpf1 activity by reducing histone acetylation by CBP/p300 and allowing Brpf1 to acetylate its target histones with reduced competition. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275 is a selective histone deacetylase inhibitor that may indirectly enhance Brpf1 activity by promoting an open chromatin state, potentially facilitating Brpf1's ability to acetylate histone targets. | ||||||
PFI-1 | 1403764-72-6 | sc-478504 | 5 mg | $98.00 | ||
PFI-1 is a BET bromodomain inhibitor that may enhance Brpf1 activity by inhibiting the binding of BET proteins to acetylated histones, potentially allowing Brpf1 to interact more effectively with its histone substrates. | ||||||